Outcome after complete percutaneous removal of infected pacemaker systems and implantable cardiac defibrillators.
The mortality of retained, infected pacemaker systems is high. We assessed the safety and rate of relapse of infection after complete percutaneous removal of leads of infected pacemaker systems. None of the 40 subjects experienced procedure-related mortality and there were no cases of relapse after a median duration of follow up of 8 years (range, 3 months to 12 years). Procedure-related complications and other adverse events during therapy are reported. Percutaneous removal of infected pacemakers in conjunction with appropriate antibiotic therapy is safe and effective.
Post
J J
JJ
Department of Infectious Diseases, Prince of Wales Hospital, Sydney, NSW, Australia. j.post@unsw.edu.au
Alexopoulos
C
C
Fewtrell
C
C
Giles
R
R
Jones
P D
PD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000628:therapy; D016470:Bacteremia / Q000209:etiology / Q000628:therapy; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000382:microbiology; D020878:Device Removal; D004696:Endocarditis / Q000209:etiology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000209:etiology / Q000628:therapy; D010138:Pacemaker, Artificial / Q000009:adverse effects / Q000382:microbiology*; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000628:therapy*; D012008:Recurrence; D012189:Retrospective Studies; D013530:Surgical Wound Infection / Q000209:etiology / Q000628:therapy; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents